Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.64 |
| ▸ | CASP7 | P55210 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | MYC | P01106 | 3/20 | 0.62 |
| ▸ | MAX | P61244 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.52 |
| ▸ | FABP3 | P05413 | 1/20 | 0.51 |
| ▸ | FABP4 | P15090 | 1/20 | 0.51 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25731196 | 0.87 | ALDH1A1 (0.61) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 | |
| SCHEMBL397773 | 0.85 | MAPK1 (0.77) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 | |
| SCHEMBL27066893 | 0.84 | ALDH1A1 (0.57) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 | |
| SCHEMBL18934842 | 0.84 | MYC (0.56) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 | |
| SCHEMBL12818174 | 0.81 | MYC (0.61) | ALDH1A1TDP1MYCMAXMEN1 | |
| SCHEMBL12595522 | 0.81 | ALDH1A1 (0.57) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 | |
| SCHEMBL31588096 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 | |
| SCHEMBL26547896 | 0.80 | ALDH1A1 (0.49) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 | |
| SCHEMBL27170189 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 | |
| SCHEMBL497457 | 0.79 | TDP1 (0.80) | ALDH1A1TDP1MAPK1CASP7L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11174258-B2 | Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes | IDEMITSU KOSAN CO., LTD. (JP) | 2021-11-16 | — | — | US | disclosed |
| EP-2362889-B1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORP (US) | 2018-12-26 | — | — | EP | disclosed |
| WO-2017093958-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO., LTD. (JP) | 2017-06-08 | — | — | WO | disclosed |
| WO-2017093958-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO., LTD. (JP) | 2017-06-08 | — | — | WO | disclosed |
| CN-102272261-B | Phosphorescent emitters | UNIVERSAL DISPLAY CORP | 2014-02-26 | — | — | CN | disclosed |
| US-20130341599-A1 | Phosphorescent Emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2013-12-26 | — | — | US | disclosed |
| CN-103396455-A | Phosphorescent emitter | UNIVERSAL DISPLAY CORP | 2013-11-20 | — | — | CN | disclosed |
| US-8367223-B2 | Heteroleptic phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2013-02-05 | — | — | US | disclosed |
| US-8367223-B2 | Heteroleptic phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2013-02-05 | — | — | US | disclosed |
| US-8367223-B2 | Heteroleptic phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2013-02-05 | — | — | US | disclosed |
| CN-102272261-A | Phosphorescent emitters | — | 2011-12-07 | — | — | CN | disclosed |
| EP-2362889-A1 | PHOSPHORESCENT EMITTERS | Universal Display Corporation (US) | 2011-09-07 | — | — | EP | disclosed |
| US-20100141127-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
| US-20100141127-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
| WO-2010056669-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-05-20 | — | — | WO | disclosed |
| WO-2010056669-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100141127-A1 | PHOSPHORESCENT EMITTERS | PAICS, TYMP, NUDT1 | ALDH1A1 695/4885TDP1 248/4885MAPK1 3727/4885 |
| US-11174258-B2 | Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes | KCNH2, KCNH3, KCNJ2 | ALDH1A1 397/4885TDP1 3736/4885MAPK1 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.